Unraveling CD69 signaling pathways, ligands and laterally associated molecules

Authors

  • Maria Jiménez-Fernández Hospital Universitario de la Princesa, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa (IIS-IP), 28006 Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), 29029 Madrid, Spain https://orcid.org/0000-0001-5972-2436
  • Hortensia de la Fuente Hospital Universitario de la Princesa, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa (IIS-IP), 28006 Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), 29029 Madrid, Spain; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain https://orcid.org/0000-0001-8708-753X
  • Pilar Martín Centro Nacional de Investigaciones Cardiovasculares (CNIC), 29029 Madrid, Spain; CIBER de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, 28029 Madrid, Spain https://orcid.org/0000-0002-2392-1764
  • Danay Cibrián Hospital Universitario de la Princesa, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa (IIS-IP), IIS-IP, c/ Diego de León, 62, 28006 Madrid, Spain. E-mail: danay.cibrian@cnic.es https://orcid.org/0000-0002-4908-2639
  • Francisco Sánchez-Madrid Hospital Universitario de la Princesa, Universidad Autónoma de Madrid (UAM), Instituto de Investigación Sanitaria del Hospital Universitario de La Princesa (IIS-IP), IIS-IP, c/ Diego de León, 62, 28006 Madrid, Spain. E-mail: fsmadrid@salud.madrid.org https://orcid.org/0000-0001-5303-0762

DOI:

https://doi.org/10.17179/excli2023-5751

Keywords:

CD69, CD69-ligands, CD69-signaling, molecular signaling-pathway

Abstract

CD69 is an early leukocyte activation marker involved in the regulation of the immune response. Initial in vitro studies evaluated its function using monoclonal antibodies until knock-out mice were developed. Subsequently, four ligands for CD69 have been identified, namely galectin-1, S100A8/S100A9 complex, myosin light chains 9 and 12, and oxidized low-density lipoproteins. In addition, several molecules are laterally associated with and regulated by CD69, including calreticulin and two transmembrane receptors, sphingosine-1-phosphate receptor (S1P1) and the heterodimeric amino acid transporter complex SLC7A5-SLC3A2 (LAT1-CD98). Recently, CD69 engagement has been shown to induce the expression of the immunoregulatory receptor programmed cell death-1 (PD-1) in T cells. The molecular signaling induced by CD69 has been explored in different scenarios and cell types. This review provides a perspective on the molecular pathways, ligands and cellular functions known to be regulated by CD69.

Published

2023-03-16

How to Cite

Jiménez-Fernández, M., de la Fuente, H., Martín, P., Cibrián, D., & Sánchez-Madrid, F. (2023). Unraveling CD69 signaling pathways, ligands and laterally associated molecules. EXCLI Journal, 22, 334–351. https://doi.org/10.17179/excli2023-5751

Issue

Section

Review articles

Categories